ProCE Banner Activity

Practice-Changing Viral Hepatitis Data From AASLD 2022

Podcast Episodes
Conference Coverage
Listen to expert insights from Nancy Reau, MD, on practice-changing viral hepatitis data from AASLD 2022, including HBV therapeutics in the pipeline, HCV management strategies, HDV screening and care linkage, fatty liver disease in patients with viral hepatitis, and the role of statins in patients with liver disease.

Released: December 06, 2022

Expiration: December 05, 2023

Share

Faculty

Nancy Reau

Nancy Reau, MD

Associate Professor of Medicine
Center for Liver Disease
University of Chicago
Chicago, Illinois

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

AbbVie Inc.

Gilead Sciences, Inc.

Faculty Disclosure

Primary Author

Nancy Reau, MD

Associate Professor of Medicine
Center for Liver Disease
University of Chicago
Chicago, Illinois

Nancy Reau, MD: consultant/advisor: AbbVie, Antios, Arbutus, Gilead Sciences, Intercept, Salix; researcher: AbbVie, Gilead Sciences, Intercept.